Analysis of differentially expressed genes between endometrial carcinosarcomas and endometrioid endometrial carcinoma by bioinformatics

详细信息    查看全文

• 作者：Hongmei Lin ; Miao Zhang ; Haifeng Yu ; Hong Zhang…
• 关键词：Con ; expressed ; Molecular mechanism ; Interaction networks
• 刊名：Archives of Gynecology and Obstetrics
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：293
• 期：5
• 页码：1073-1079
• 全文大小：766 KB
• 参考文献：1.D’angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116:131–139CrossRef PubMed
  2.Barak F, Kalichman L, Gdalevich M et al (2013) The influence of early diagnosis of endometrioid endometrial cancer on disease stage and survival. Arch Gynecol Obstet 288:1361–1364CrossRef PubMed
  3.Mccluggage W (2002) Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 12:687–690CrossRef PubMed
  4.Wolfson AH, Brady MF, Rocereto T et al (2007) A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus. Gynecol Oncol 107:177–185CrossRef PubMed PubMedCentral
  5.Menczer J, Levy T, Piura B et al (2005) A comparison between different postoperative treatment modalities of uterine carcinosarcoma. Gynecol Oncol 97:166–170CrossRef PubMed
  6.Bansal N, Yendluri V, Wenham RM (2009) The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 16:8PubMed
  7.Oda K, Stokoe D, Taketani Y, Mccormick F (2005) High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res 65:10669–10673CrossRef PubMed
  8.Catasus L, Gallardo A, Cuatrecasas M, Prat J (2009) Concomitant PI3K–AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis. Mod Pathol 22:522–529CrossRef PubMed
  9.Li L, Xu D-B, Zhao X-L, Hao T-Y (2013) Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer. Arch Gynecol Obstet 288:155–165CrossRef PubMed
  10.Jongen V, Briët J, De Jong R et al (2009) Expression of estrogen receptor-alpha and-beta and progesterone receptor-A and-B in a large cohort of patients with endometrioid endometrial cancer. Gynecol Oncol 112:537–542CrossRef PubMed
  11.Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH (2003) Coordinate expression of Cdc25B and ER-α is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas. Cancer Res 63:6195–6199PubMed
  12.Romero-Pérez L, Castilla M, López-García M et al (2013) Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis. Hum Pathol 44:244–254CrossRef PubMed
  13.Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116–5121CrossRef PubMed PubMedCentral
  14.Tan H, Tian Y, Yang H, Liu G, Nie L (2002) A novel Streptomyces gene, samR, with different effects on differentiation of Streptomyces ansochromogenes and Streptomyces coelicolor. Arch Microbiol 177:274–278CrossRef PubMed
  15.Mcclure R, Balasubramanian D, Sun Y et al (2013) Computational analysis of bacterial RNA-Seq data. Nucleic Acids Res 41:e140CrossRef PubMed PubMedCentral
  16.Peri S, Navarro JD, Kristiansen TZ et al (2004) Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 32:D497–D501CrossRef PubMed PubMedCentral
  17.Junker BH, Koschützki D, Schreiber F (2006) Exploration of biological network centralities with CentiBiN. BMC Bioinformatics 7:219CrossRef PubMed PubMedCentral
  18.Huang DW, Sherman BT, Lempicki RA (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57CrossRef
  19.Kanehisa M (2002) The KEGG database. Silico Simul Biol Processes 247:103
  20.Ahmed J, Meinel T, Dunkel M et al (2011) CancerResource: a comprehensive database of cancer-relevant proteins and compound interactions supported by experimental knowledge. Nucleic Acids Res 39:D960–D967CrossRef PubMed PubMedCentral
  21.Alibés A, Yankilevich P, Díaz-Uriarte R (2007) IDconverter and IDClight: conversion and annotation of gene and protein IDs. BMC Bioinformatics 8:9CrossRef PubMed PubMedCentral
  22.Šubelj L, Bajec M (2011) Unfolding communities in large complex networks: combining defensive and offensive label propagation for core extraction. Phys Rev A 83:036103
  23.Risinger JI, Dent GA, Ignar-Trowbridge D, Mclachlan JA, Tsao MS, Senterman M, Boyd J (1992) p53 gene mutations in human endometrial carcinoma. Mol Carcinog 5:250–253CrossRef PubMed
  24.Koul A, Willén R, Bendahl PO, Nilbert M, Borg (2002) Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Cancer 94:2369–2379CrossRef PubMed
  25.Sung C, Zheng Y, Quddus M, Kang X, Zhang ZF, Lauchlan S, Zheng W (2000) p53 as a significant prognostic marker in endometrial carcinoma. Int J Gynecol Cancer 10:119–127CrossRef PubMed
  26.Skomedal H, Kristensen GB, Nesland JM, Børresen-Dale AL, Tropé C, Holm R (1999) TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus. J Pathol 187:556–562CrossRef PubMed
  27.Milde-Langosch K, Bamberger A-M, Goemann C, Rössing E, Rieck G, Kelp B, Löning T (2001) Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J Cancer Res Clin Oncol 127:537–544CrossRef PubMed
  28.Götte M, Greve B, Kelsch R et al (2011) The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1. Int J Cancer 129:2042–2049CrossRef PubMed
  29.Semczuk A, Miturski R, Skomra D, Jakowicki JA (2004) Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features. Arch Gynecol Obstet 269:104–110CrossRef PubMed
  30.Cheung LW, Hennessy BT, Li J et al (2011) High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov 1:170–185CrossRef PubMed PubMedCentral
  31.Jiang B-H, Liu L-Z (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784:150–158CrossRef PubMed
  32.Saegusa M, Hashimura M, Kuwata T, Okayasu I (2009) Requirement of the Akt/β-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of Slug. Am J Pathol 174:2107–2115CrossRef PubMed PubMedCentral
  33.Slomovitz BM, Coleman RL (2012) The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res 18:5856–5864CrossRef PubMed
  34.Sianou A, Galyfos G, Moragianni D, Andromidas P, Kaparos G, Baka S, Kouskouni E (2015) The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review. Arch Gynecol Obstet 292:1–12CrossRef
  35.Chen C, Hsieh F, Lieblein J et al (2007) Stat3 activation in human endometrial and cervical cancers. Br J Cancer 96:591–599CrossRef PubMed PubMedCentral
  36.Tang J-Z, Kong X-J, Banerjee A et al (2010) STAT3α is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone. Endocrinology 151:4133–4145CrossRef PubMed
  37.Koontz JI, Soreng AL, Nucci M et al (2001) Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 98:6348–6353CrossRef PubMed PubMedCentral
  38.Jakate K, Azimi F, Ali RH et al (2012) Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors. Mod Pathol 26:95–105CrossRef PubMed
  
• 作者单位：Hongmei Lin (1)
  Miao Zhang (1)
  Haifeng Yu (1)
  Hong Zhang (1)
  Yuanfang Li (1)
  Jian Xu (1)
  Xuehua Chen (1)
  Yana Chen (1)
  
  1. Shandong University Affiliated Jinan Center Hospital, No. 105 Jiefang Road, Jinan, 250013, Shandong, China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Gynecology
  Obstetrics and Perinatology
  Endocrinology
  Human Genetics
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-0711

文摘

Purpose This study aimed to explore the underlying molecular mechanisms of endometrial carcinosarcomas (ECS) and endometrioid endometrial carcinoma (EEC) by bioinformatics analysis.